Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.871,23
0,22%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Opko Health Inc (OPK) Opko Health Inc (OPK) Notizie

OPK

Opko Health (OPK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OPK
DataOraFonteTitoloSimboloCompagnia
31/05/202416:48GlobeNewswire Inc.OPKO Health to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:OPKOpko Health Inc
07/05/202422:29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPKOpko Health Inc
07/05/202422:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
07/05/202422:05GlobeNewswire Inc.OPKO Health Reports First Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
03/05/202414:00GlobeNewswire Inc.OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:OPKOpko Health Inc
28/03/202413:00PR Newswire (US)Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessNASDAQ:OPKOpko Health Inc
20/03/202413:00GlobeNewswire Inc.Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel SyndromeNASDAQ:OPKOpko Health Inc
07/03/202422:02Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:OPKOpko Health Inc
05/03/202414:52GlobeNewswire Inc.AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIVNASDAQ:OPKOpko Health Inc
01/03/202422:05Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:OPKOpko Health Inc
28/02/202415:31PR Newswire (US)NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1stNASDAQ:OPKOpko Health Inc
27/02/202422:05GlobeNewswire Inc.OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
22/02/202422:05GlobeNewswire Inc.OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024NASDAQ:OPKOpko Health Inc
16/02/202422:53Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:OPKOpko Health Inc
05/02/202414:09PR Newswire (US)NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in ChinaNASDAQ:OPKOpko Health Inc
29/01/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
24/01/202422:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:OPKOpko Health Inc
09/01/202422:05GlobeNewswire Inc.OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional NotesNASDAQ:OPKOpko Health Inc
08/01/202414:00GlobeNewswire Inc.OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:OPKOpko Health Inc
05/01/202405:31GlobeNewswire Inc.OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029NASDAQ:OPKOpko Health Inc
03/01/202423:05GlobeNewswire Inc.OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029NASDAQ:OPKOpko Health Inc
28/11/202313:00PR Newswire (US)BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and TestingNASDAQ:OPKOpko Health Inc
07/11/202312:45PR Newswire (US)BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™NASDAQ:OPKOpko Health Inc
06/11/202322:05GlobeNewswire Inc.OPKO Health Reports Third Quarter 2023 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
02/11/202315:00GlobeNewswire Inc.New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023NASDAQ:OPKOpko Health Inc
31/10/202321:08Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OPKOpko Health Inc
31/10/202313:00GlobeNewswire Inc.OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023NASDAQ:OPKOpko Health Inc
25/10/202322:25GlobeNewswire Inc.OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023NASDAQ:OPKOpko Health Inc
28/09/202323:10Dow Jones NewsModeX Therapeutics Awarded Contract to Address Public Health Threat From Viral DiseasesNASDAQ:OPKOpko Health Inc
28/09/202322:08GlobeNewswire Inc.ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease ThreatsNASDAQ:OPKOpko Health Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OPK

La tua Cronologia

BIT
UCG
Unicredit
BIT
TIT
Telecom Italia
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
STMMI
ST Microelectronics
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TITR
Telecom Italia
BIT
ENEL
Enel
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
PIRC
Pirelli & C
BIT
SPM
Saipem
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network